JH

Janus Henderson

Description

Janus Henderson

Investor Profile

Janus Henderson has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series D rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biopharma, Biotechnology, Pharmaceutical.

Stage Focus

  • Series B (50%)
  • Series D (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Pharmaceutical
  • Augmented Reality
  • Computer Vision
  • Generative Ai
  • Video
  • Wearables
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Janus Henderson frequently co-invest with?

Alibaba Group
Asia, Zhejiang, China, Hangzhou
Co-Investments: 1
CA
North America, Massachusetts, United States, Boston
Co-Investments: 1
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 1
Amzak Health Investors
North America, New York, United States, New York
Co-Investments: 1
Viking Global Investors
North America, Connecticut, United States, Stamford
Co-Investments: 1
EDBI
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 1
BridgeBio
North America, California, United States, Palo Alto
Co-Investments: 1
Aisling Capital
North America, New York, United States, New York
Co-Investments: 1
Fidelity
North America, Massachusetts, United States, Boston
Co-Investments: 1

What are some of recent deals done by Janus Henderson?

ProMIS Neurosciences

Toronto, Ontario, Canada

ProMIS Neurosciences develops therapeutic products and diagnostic devices targeting misfolded protein diseases.

BiotechnologyHealth DiagnosticsMedicalNeuroscienceTherapeutics
Post Ipo EquityJan 30, 2026
Amount Raised: $175,000,000
Eidos Therapeutics

Palo Alto, California, United States

Eidos Therapeutics is a clinical-stage biotech company developing novel, genetically targeted therapies to improve the lives of patients.

BiopharmaBiotechnologyPharmaceutical
Series BApr 5, 2018
Amount Raised: $64,000,000
Magic Leap

Plantation, Florida, United States

Magic Leap is a proprietary wearable technology that enables users to interact with digital devices in a completely visually cinematic way.

Augmented RealityComputer VisionGenerative AIVideoWearables
Series DOct 17, 2017
Amount Raised: $502,000,000

Find More Investors Like Janus Henderson

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Janus Henderson | Pipeseed